Aliskiren - Hypertension
You are here : Home > Formulary Search > Aliskiren - Hypertension
Status 1
- Not Specified
Documentation
PAD Profile
Other Indications
Below are listed other indications that Aliskiren is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hypertension.
- Amlodipine
- Atenolol
- Azilsartan medoxomil
- Bendroflumethiazide
- Bisoprolol fumarate
- Candesartan cilexetil
- Captopril
- Carvedilol
- Celiprolol hydrochloride
- Chlortalidone
- Clonidine hydrochloride
- Co-tenidone (Atenolol/chlortalidone)
- Diltiazem hydrochloride
- Doxazosin mesilate
- Enalapril maleate
- Eprosartan
- Hydralazine hydrochloride
- Indapamide
- Irbesartan
- Irbesartan / Hydrochlorothiazide
- Lercanidipine hydrochloride
- Lisinopril
- Lisinopril / Hydrochlorothiazide
- Losartan potassium
- Metolazone
- Metoprolol tartrate
- Moxonidine
- Nebivolol
- Nicardipine hydrochloride
- Nifedipine
- Olmesartan medoxomil
- Perindopril arginine
- Perindopril erbumine
- Prazosin hydrochloride
- Propranolol hydrochloride
- Quinapril hydrochloride
- Ramipril
- Spironolactone
- Telmisartan
- Valsartan
- Valsartan with hydrochlorothiazide
Committee Recommendations (2)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
The Area Prescribing Committee does not recommend the use of aliskiren in line with NHS England guidance.
Aliskiren will be considered BLACK on the traffic light system. Prescribers should:
- NOT initiate aliskiren for any new patient
AND
- Change patients taking aliskiren to an alternative antihypertensive in line with NICE on the diagnosis and management of hypertension in adults noting that it is important that blood pressure is monitored closely and to consider treatments that may not have previously been used OR
- Patients should be referred into a specialist for consideration of de-prescribing if appropriate